Evidence map›Paper›PMID 34943496›Full record

ReviewDiagnostics (Basel, Switzerland)2021

Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation.

Barbara Bonnesen, Jens-Ulrik Stæhr Jensen, Klaus Nielsen Jeschke, Alexander G Mathioudakis, Alexandru Corlateanu, Ejvind Frausing Hansen, Ulla Møller Weinreich, Ole Hilberg, Pradeesh Sivapalan

Open access · goldAbstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Distinct Features of Vascular Diseases in COVID-19.Journal of inflammation research · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Barbara BonnesenDepartment of Medicine, Section of Respiratory Medicine, Herlev and Gentofte Hospital, University of Copenhagen, 2200 Copenhagen, Denmark.
Jens-Ulrik Stæhr JensenDepartment of Medicine, Section of Respiratory Medicine, Herlev and Gentofte Hospital, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0003-4036-0521
Klaus Nielsen JeschkeDepartment of Respiratory Medicine, Copenhagen University Hospital-Hvidovre, 2650 Hvidovre, Denmark.ORCID 0000-0002-7743-4486
Alexander G MathioudakisDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester M23 9LT, UK.ORCID 0000-0002-4675-9616
Alexandru CorlateanuDepartment of Respiratory Medicine, State University of Medicine and Pharmacy "Nicolae Testemitanu", 2004 Chisinau, Moldova.ORCID 0000-0002-3278-436X
Ejvind Frausing HansenDepartment of Respiratory Medicine, Copenhagen University Hospital-Hvidovre, 2650 Hvidovre, Denmark.ORCID 0000-0002-7269-0712
Ulla Møller WeinreichDepartment of Respiratory Medicine, Aalborg University Hospital, University of Aalborg, 9100 Aalborg, Denmark.
Ole HilbergDepartment of Medicine, Little Belt Hospital, 7100 Vejle, Denmark.
Pradeesh SivapalanDepartment of Medicine, Section of Respiratory Medicine, Herlev and Gentofte Hospital, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-8620-3655
University of Copenhagen · DKHvidovre Hospital · DKAalborg University Hospital · DKManchester Academic Health Science Centre · GBNicolae Testemițanu State University of Medicine and Pharmacy · MDUniversity of Southern Denmark · DK

Funding

Novo Nordisk Foundation 0060657
6 · The paper itself

Abstract

Patients admitted to hospital with coronavirus disease 2019 (COVID-19) may develop acute respiratory failure (ARF) with compromised gas exchange. These patients require oxygen and possibly ventilatory support, which can be delivered via different devices. Initially, oxygen therapy will often be administered through a conventional binasal oxygen catheter or air-entrainment mask. However, when higher rates of oxygen flow are needed, patients are often stepped up to high-flow nasal cannula oxygen therapy (HFNC), continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP), or invasive mechanical ventilation (IMV). BiPAP, CPAP, and HFNC may be beneficial alternatives to IMV for COVID-19-associated ARF. Current evidence suggests that when nasal catheter oxygen therapy is insufficient for adequate oxygenation of patients with COVID-19-associated ARF, CPAP should be provided for prolonged periods. Subsequent escalation to IMV may be implemented if necessary.

Indexed as

acute respiratory failurebilevel positive airway pressureBiPAPcontinuous positive airway pressureCOVID-19CPAPHFNChigh-flow nasal cannula oxygen therapyNIVnoninvasive ventilation

Identifiers

PMID34943496
PMCPMC8700515
OpenAlexW3215279726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.